Journal article
Favorable Outcomes from Allogeneic and Autologous Stem Cell Transplantation for Patients with Transformed Nonfollicular Indolent Lymphoma
Abstract
The role of allogeneic (allo-) and autologous stem cell transplantation (auto-SCT) in the management of patients with transformed indolent nonfollicular non-Hodgkin lymphoma is unknown. This is a multicenter, retrospective cohort study of patients with biopsy-proven indolent B cell nonfollicular non-Hodgkin lymphoma and simultaneous or subsequent biopsy-proven aggressive histology transformation who were treated with allo-SCT or auto-SCT …
Authors
Villa D; George A; Seymour JF; Toze CL; Crump M; Lee C; Buckstein R; Stewart DA; MacDonald D; Foley R
Journal
Transplantation and Cellular Therapy, Vol. 20, No. 11, pp. 1813–1818
Publisher
Elsevier
Publication Date
November 2014
DOI
10.1016/j.bbmt.2014.07.015
ISSN
2666-6367
Associated Experts
Fields of Research (FoR)
Sustainable Development Goals (SDG)
Medical Subject Headings (MeSH)
AdultAgedAnthracyclinesAntibodies, Monoclonal, Murine-DerivedAntineoplastic Combined Chemotherapy ProtocolsCohort StudiesCombined Modality TherapyDisease-Free SurvivalFemaleHematopoietic Stem Cell TransplantationHumansLymphoma, B-CellMaleMiddle AgedOrganoplatinum CompoundsRetrospective StudiesRituximabSurvival RateTransplantation ConditioningTreatment Outcome